Tyra Biosciences, Inc. (TYRA)
NASDAQ: TYRA · Real-Time Price · USD
10.73
+0.13 (1.23%)
At close: Aug 13, 2025, 4:00 PM
10.75
+0.02 (0.19%)
After-hours: Aug 13, 2025, 4:36 PM EDT
United States Steel Market Cap
Tyra Biosciences has a market cap or net worth of $571.66 million as of August 13, 2025. Its market cap has decreased by -45.82% in one year.
Market Cap
571.66M
Enterprise Value
258.84M
1-Year Change
-45.82%
Ranking
Category
Stock Price
$10.73
Market Cap Chart
Since the IPO on September 15, 2021, Tyra Biosciences's market cap has decreased from $654.64M to $571.66M, a decrease of -12.68%. That is a compound annual growth rate of -3.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 12, 2025 | 563.69M | -22.91% |
| Dec 31, 2024 | 731.18M | 22.61% |
| Dec 29, 2023 | 596.34M | 87.61% |
| Dec 30, 2022 | 317.87M | -44.42% |
| Dec 31, 2021 | 571.90M | -12.64% |
| Sep 15, 2021 | 654.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 574.04B |
| Johnson & Johnson | 416.11B |
| AbbVie | 350.91B |
| UnitedHealth Group | 236.90B |
| AstraZeneca | 232.33B |
| Novartis AG | 230.64B |
| Abbott Laboratories | 228.03B |
| Novo Nordisk | 223.00B |